Skip to main content
Advertisement
Advertisement
PSNL
PSNL logo
Personalis, Inc. Common Stock
15.71
USD
Sponsored
-0.15
-0.95%
Nov 13, 15:59 UTC -5
Closed
exchange

After-Market

15.71

-0.01
-0.03%

Personalis, Inc. Common Stock (PSNL) Earnings

PSNL Earnings Reports

Positive Surprise Ratio

PSNL beat 19 of 30 last estimates.

63%

Next Report

Date of Next Report
Feb 24, 2027
Estimate for Q4 26 (Revenue/ EPS)
$25.53M
/
-$0.24
Implied change from Q3 26 (Revenue/ EPS)
-0.28%
/
-25.00%
Implied change from Q4 25 (Revenue/ EPS)
+47.16%
/
-7.69%

Personalis, Inc. Common Stock earnings per share and revenue

On Nov 04, 2026, PSNL reported earnings of -0.32 USD per share (EPS) for Q3 26, missing the estimate of -0.25 USD, resulting in a -24.08% surprise. Revenue reached 25.60 million, compared to an expected 22.29 million, with a 14.85% difference. The market reacted with a -1.52% price change (close before vs. close after earnings).
Looking ahead to Q4 26, 8 analysts forecast an EPS of -0.24 USD, with revenue projected to reach 25.53 million USD, implying an decrease of -25.00% EPS, and decrease of -0.28% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Taysha Gene Therapies, Inc. Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.13
Actual
-$0.10
Surprise
+24.59%
logo
Amphastar Pharmaceuticals, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.87
Actual
$1.13
Surprise
+30.18%
logo
Sol-Gel Technologies Ltd. Ordinary Shares
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$2.11
Actual
-$1.72
Surprise
+18.67%
logo
Teva Pharmaceutical Industries Limited
Report Date
Nov 03, 2026 For Q3 26
Estimate
$0.74
Actual
$0.86
Surprise
+15.50%
logo
Metagenomi Therapeutics, Inc. Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.64
Actual
-$0.56
Surprise
+13.31%
FAQ
For Q3 2026, Personalis, Inc. Common Stock reported EPS of -$0.32, missing estimates by -24.08%, and revenue of $25.60M, 14.85% above expectations.
The stock price moved down -1.52%, changed from $15.79 before the earnings release to $15.55 the day after.
The next earning report is scheduled for Feb 24, 2027.
Based on 8 analysts, Personalis, Inc. Common Stock is expected to report EPS of -$0.24 and revenue of $25.53M for Q4 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement